Medtronic Launches GI Genius™ Intelligent Endoscopy Module
Strategic Development The US Food and Drug Administration (FDA) granted de novo clearance for the GI Genius™ intelligent endoscopy module in the United States, developed by Medtronic in partnership with Cosmo Pharmaceuticals. The GI Genius module is the first and only commercially available artificial intelligence (AI)-based computer-aided detection (CADe)...
Nurturing Innovations With Technology Scouting
One important lesson the COVID-19 pandemic has taught us to refrain from getting stagnant and always keep looking for new technologies useful in the present and prove to be helpful in the future. In this fast-paced environment, each company is looking for new technologies to enhance their portfolio and...
Amoeba Biology Provides A Significant Lung Disease Treatment Target
Picture Credit: Corinne Sandone, Johns Hopkins Medicine Strategic Development In a series of experiments that began with amoebas — single-celled species with podlike appendages that help them move around — Johns Hopkins Medicine researchers believe they have discovered a genetic mechanism that could be triggered to help sweep mucus...
COVID 19 Update – Rich Countries Signed Away The Opportunity To Vaccinate The Whole World
In the industry news, we showcase our analytical viewpoint on development in the market, aligning with a company’s future growth initiatives. It entails a holistic impact across the organization, its end-users, and peer industry participants. Furthermore, it will also represent the shifting trends across the industry ecosystem. Strategic Development...
Overcoming The Challenges Of CAR T-Cell Therapy Development
In today’s world, there is no scarier disease than cancer. Cancer is often considered deadly and untreatable, supported by the fact that cancer has been one of the crucial causes of mortality globally. In 2020, there were approximately 19.3 million new cancer cases and almost 10.0 million cancer deaths....
Exscientia Announces Clinical Trials For The First AI-Designed Immuno-Oncology Drug
Strategic Development Exscientia Ltd., a leading AI-driven Pharmatech firm, announced that the world’s first AI-designed immuno-oncology molecule had entered human clinical trials. Exscientia and Evotec collaborated to co-invent and develop the A2a receptor antagonist, which is being formulated for adult patients with advanced solid tumors. Strategic Alignment Adenosine A2A...
AI In Well Being And Comfort In Automotive Industry
Can we imagine a day without riding our vehicle or hoping for some other kind of vehicle? In our luxurious lifestyle, Automotive Industry is one of the essentials of human lives. The automotive industry evolves with trends and discoveries. AI is implemented rapidly in various sectors, and the way...
Rarecell Developed An Approach For Tumor Cell Characterization
Strategic Development Rarecells Inc., a leading Liquid Biopsy company, announces the development of a revolutionary and accurate targeted digital single-cell Next-Generation Sequencing (scNGS) for single-nucleotide variant (SNV) method to detect mutant genes of pancreatic ductal adenocarcinoma (PDAC) circulating tumor cells (CTC) enriched by the ISET technology. Strategic Alignment Using...
MindMed Published New Optimized Data On Personalized MDMA Dosing
In the industry news domain, IEBS showcases its analytical viewpoint on development in the market that aligns with its upcoming growth initiatives. It entails a holistic impact across the organization, its end-users, and peer industry participants. Moreover, it will also represent the shifting trends across the industry ecosystem. Strategic...
Establishing An Effective Business Ecosystem
A company cannot flourish as an independent entity in the business domain. It exists as a part of an entire ecosystem. A player ecosystem is defined as the network of organizations that includes suppliers, distributors, competitors, customers, government agencies, etc. All these organizations are involved in delivering products and...